Literature DB >> 20371666

Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study.

Christian Otte1, Stefan Wüst, Shoujun Zhao, Ludmila Pawlikowska, Pui-Yan Kwok, Mary A Whooley.   

Abstract

CONTEXT: A common haplotype of the glucocorticoid receptor (GR) gene has been associated with increased susceptibility to coronary heart disease (CHD). Whether this haplotype predisposes to heart failure (HF) is unknown.
OBJECTIVE: The objective of the study was to determine whether GR haplotype 3 is associated with HF and whether this association is explained by low-grade inflammation (C-reactive protein).
DESIGN: In a prospective cohort study, participants were genotyped for common GR gene polymorphisms (ER22/23EK, BclI C/G, N363S, 9beta A/G). Haplotype analyses were conducted.
SETTING: The study was conducted at one university medical center, two Veterans Affairs medical centers, and nine public health clinics. PATIENTS: Patients included 526 white outpatients with stable CHD. MAIN OUTCOME MEASURES: Echocardiographic evidence of ventricular dysfunction, self-reported heart failure, and subsequent hospitalization for heart failure were measured.
RESULTS: After adjusting for age, sex, smoking, and body mass index, participants with two copies of haplotype 3 were more likely than those with 0 or 1 copy to report heart failure [hazard ratio (HR) 4.15, 95% confidence interval (CI) 1.5-11.3, P < 0.01], have systolic dysfunction (left ventricular ejection fraction <50%) (HR 3.0, 95% CI 0.9-9.9, P = 0.07), and be hospitalized for HF during a mean follow-up of 6 yr (HR 3.0, 95% CI 1.3-7.0, P = 0.01). These associations were attenuated after adjustment for higher C-reactive protein levels in patients with two copies of haplotype 3.
CONCLUSIONS: We found that the GR gene haplotype 3 was associated with prevalent HF, systolic dysfunction, and subsequent HF hospitalization in patients with CHD. This association was partly mediated by low-grade inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20371666     DOI: 10.1210/jc.2009-2251

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

2.  Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptor.

Authors:  Shannon D Whirledge; Christine M Jewell; Lisa M Barber; Xiaojiang Xu; Kevin S Katen; Stavros Garantziotis; John A Cidlowski
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

3.  Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration.

Authors:  Mary A Dwyer; Dmitri Kazmin; Peng Hu; Donald P McDonnell; Goldis Malek
Journal:  Mol Endocrinol       Date:  2011-01-14

Review 4.  Role of the glucocorticoid receptor in glomerular disease.

Authors:  Julie E Goodwin
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-05

5.  Circulating Interleukin-6 concentration covaries inversely with self-reported sleep duration as a function of polymorphic variation in the glucocorticoid receptor.

Authors:  Catherine P Walsh; Alvin Lim; Anna L Marsland; Robert E Ferrell; Stephen B Manuck
Journal:  Brain Behav Immun       Date:  2019-01-11       Impact factor: 7.217

Review 6.  Glucocorticoid signaling in the heart: A cardiomyocyte perspective.

Authors:  Robert H Oakley; John A Cidlowski
Journal:  J Steroid Biochem Mol Biol       Date:  2015-03-21       Impact factor: 4.292

Review 7.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

Review 8.  Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.

Authors:  Evangelia Charmandari; Tomoshige Kino; George P Chrousos
Journal:  Endocr Dev       Date:  2013-02-01

9.  MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2.

Authors:  Amanda L Clark; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

10.  Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease.

Authors:  Robert H Oakley; Rongqin Ren; Diana Cruz-Topete; Gary S Bird; Page H Myers; Michael C Boyle; Michael D Schneider; Monte S Willis; John A Cidlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.